Bayer shareholders appeared cautiously optimistic after worrying that the German drugs and chemicals giant could overpay, while some Monsanto shareholders said they had envisioned a higher price for the world’s largest developer of high-tech crop seeds.
from WSJ.com: US Business http://ift.tt/2cbzoX7
via IFTTT
No comments:
Post a Comment